TrialInfluenza and other respiratory viruses2018

The safety and efficacy of quadrivalent live attenuated influenza vaccine in Japanese children aged 2-18 years: Results of two phase 3 studies.

Raburn M Mallory et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.